Too many follistatins: Racing inside and getting out of the cell

Endocrinology

Volumn 146, Issue 12, 2005, Pages 5048-5051

  Kumar, T Rajendra ^a,b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLISTATIN; RNA;

ALTERNATIVE RNA SPLICING; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CELLULAR DISTRIBUTION; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE STRUCTURE; HELA CELL; HORMONAL REGULATION; HORMONE INHIBITION; HUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; SHORT SURVEY; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

ANIMALS; CELLS; FOLLISTATIN; FOLLISTATIN-RELATED PROTEINS; HUMANS; PROTEIN ISOFORMS;

EID: 27844569857     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1210     Document Type: Short Survey

References (37)

1. Esch FS, Shimasaki S, Mercado M, Cooksey K, Ling N, Ying S, Ueno N, Guillemin R 1987 Structural characterization of follistatin: a novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad. Mol Endocrinol 1:849-855
2. Ueno N, Ling N, Ying SY, Esch F, Shimasaki S, Guillemin R 1987 Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc Natl Acad Sci USA 84:8282-8286
3. Ying SY, Becker A, Swanson G, Tan P, Ling N, Esch F, Ueno N, Shimasaki S, Guillemin R 1987 Follistatin specifically inhibits pituitary follicle stimulating hormone release in vitro. Biochem Biophys Res Commun 149:133-139
4. Shimasaki S, Koga M, Esch F, Mercado M, Cooksey K, Koba A, Ling N 1988 Porcine follistatin gene structure supports two forms of mature follistatin produced by alternative splicing. Biochem Biophys Res Commun 152:717-723
5. Shimasaki S, Koga M, Buscaglia ML, Simmons DM, Bicsak TA, Ling N 1989 Follistatin gene expression in the ovary and extragonadal tissues. Mol Endocrinol 3:651-659
6. Bilezikjian LM, Blount AL, Corrigan AZ, Leal A, Chen Y, Vale WW 2001 Actions of activins, inhibins and follistatins: implications in anterior pituitary function. Clin Exp Pharmacol Physiol 28:244-248
7. Welt C, Sidis Y, Keutmann H, Schneyer A 2002 Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood) 227:724-752
8. Bilezikjian LM, Blount AL, Leal AM, Donaldson CJ, Fischer WH, Vale WW 2004 Autocrine/paracrine regulation of pituitary function by activin, inhibin and follistatin. Mol Cell Endocrinol 225:29-36
9. Matzuk MM, Kumar TR, Shou W, Coerver KA, Lau AL, Behringer RR, Finegold MJ 1996 Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development. Recent Prog Horm Res 51:123-154; discussion 155-157
10. Harrison CA, Gray PC, Vale WW, Robertson DM 2005 Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab 16:73-78
11. Matzuk MM, Lu N, Vogel H, Sellheyer K, Roop DR, Bradley A 1995 Multiple defects and perinatal death in mice deficient in follistatin. Nature 374:360-363
12. Guo Q, Kumar TR, Woodruff T, Hadsell LA, DeMayo FJ, Matzuk MM 1998 Overexpression of mouse follistatin causes reproductive defects in transgenic mice. Mol Endocrinol 12:96-106
13. Jorgez CJ, Klysik M, Jamin SP, Behringer RR, Matzuk MM 2004 Granulosa cell-specific inactivation of follistatin causes female fertility defects. Mol Endocrinol 18:953-967
14. Xia Y, Sidis Y, Schneyer A 2004 Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice. Mol Endocrinol 18:979-994
15. Saito S, Sidis Y, Mukherjee A, Xia Y, Schneyer A 2005 Differential biosynthesis and intracellular transport of follistatin isoforms and follistatin-like-3. Endocrinology 146:5052-5062
16. Inouye S, Guo Y, DePaolo L, Shimonaka M, Ling N, Shimasaki S 1991 Recombinant expression of human follistatin with 315 and 288 amino acids: chemical and biological comparison with native porcine follistatin. Endocrinology 129:815-822
17. Krummen LA, Woodruff TK, DeGuzman G, Cox ET, Baly DL, Mann E, Garg S, Wong WL, Cossum P, Mather JP 1993 Identification and characterization of binding proteins for inhibin and activin in human serum and follicular fluids. Endocrinology 132:431-443
18. Sidis Y, Schneyer AL, Keutmann HT 2005 Heparin and activin-binding determinants in follistatin and FSTL3. Endocrinology 146:130-136
19. Inouye S, Ling N, Shimasaki S 1992 Localization of the heparin binding site of follistatin. Mol Cell Endocrinol 90:1-6
20. Sumitomo S, Inouye S, Liu XJ, Ling N, Shimasaki S 1995 The heparin binding site of follistatin is involved in its interaction with activin. Biochem Biophys Res Commun 208:1-9
21. Wang Q, Keutmann HT, Schneyer AL, Sluss PM 2000 Analysis of human follistatin structure: identification of two discontinuous N-terminal sequences coding for activin A binding and structural consequences of activin binding to native proteins. Endocrinology 141:3183-3193
22. Keutmann HT, Schneyer AL, Sidis Y 2004 The role of follistatin domains in follistatin biological action. Mol Endocrinol 18:228-240
23. Schneyer A, Tortoriello D, Sidis Y, Keutmann H, Matsuzaki T, Holmes W 2001 Follistatin-related protein (FSRP): a new member of the follistatin gene family. Mol Cell Endocrinol 180:33-38
24. Tortoriello DV, Sidis Y, Holtzman DA, Holmes WE, Schneyer AL 2001 Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. Endocrinology 142:3426-3434
25. Sidis Y, Tortoriello DV, Holmes WE, Pan Y, Keutmann HT, Schneyer AL 2002 Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin. Endocrinology 143:1613-1624
26. Schneyer A, Schoen A, Quigg A, Sidis Y 2003 Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG). Endocrinology 144:1671-1674
27. Schneyer A, Sidis Y, Xia Y, Saito S, del Re E, Lin HY, Keutmann H 2004 Differential actions of follistatin and follistatin-like 3. Mol Cell Endocrinol 225:25-28
28. Schneyer AL, Wang Q, Sidis Y, Sluss PM 2004 Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay. J Clin Endocrinol Metab 89:5067-5075
29. Nakamura M, Matzuk MM, Gerstmayer B, Bosio A, Lauster R, Miyachi Y, Werner S, Paus R 2003 Control of pelage hair follicle development and cycling by complex interactions between follistatin and activin. FASEB J 17:497-499
30. Wang XP, Suomalainen M, Jorgez CJ, Matzuk MM, Werner S, Thesleff I 2004 Follistatin regulates enamel patterning in mouse incisors by asymmetrically inhibiting BMP signaling and ameloblast differentiation. Dev Cell 7:719-730
31. Yao HH, Matzuk MM, Jorgez CJ, Menke DB, Page DC, Swain A, Capel B 2004 Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Dev Dyn 230:210-215
32. Jans DA, Hassan G 1998 Nuclear targeting by growth factors, cytokines, and their receptors: a role in signaling? Bioessays 20:400-411
33. Johnson HM, Subramaniam PS, Olsnes S, Jans DA 2004 Trafficking and signaling pathways of nuclear localizing protein ligands and their receptors. Bioessays 26:993-1004
34. Yudt MR, Cidlowski JA 2001 Molecular identification and characterization of a and b forms of the glucocorticoid receptor. Mol Endocrinol 15:1093-1103
35. Yudt MR, Cidlowski JA 2002 The glucocorticoid receptor: coding a diversity of proteins and responses through a single gene. Mol Endocrinol 16:1719-1726
36. Fiaschi-Taesch NM, Stewart AF 2003 Minireview: parathyroid hormone-related protein as an intracrine factor - trafficking mechanisms and functional consequences. Endocrinology 144:407-411
37. Tsuchida K, Nakatani M, Matsuzaki T, Yamakawa N, Liu Z, Bao Y, Arai KY, Murakami T, Takehara Y, Kurisaki A, Sugino H 2004 Novel factors in regulation of activin signaling. Mol Cell Endocrinol 225:1-8